D-Dimer Market to Reap Excessive Revenues by 2025

Veröffentlicht von: Persistence Market Research
Veröffentlicht am: 15.01.2018 13:32
Rubrik: Handel & Wirtschaft


(Presseportal openBroadcast) - D-dimer comprises of two D fragments of the fibrin protein that get cross-linked after fibrinolysis of a blood clot, which is found in the human blood samples. The concentration of these D-dimers present in the patient blood samples help in the diagnosis of thrombosis. This test becomes very useful for those patients who are susceptible towards thrombotic disorders like venous thromboembolism.On the basis of disease diagnoses, the D-dimer market can be classified into three major segments namely, pulmonary embolism, deep venous thrombosis and others.

Request to Browse Full Table of Content, figure and Tables @ https://www.persistencemarketresearch.com/toc/20632

Major driving factors for the growth of this market include, increasing prevalence of various cardiovascular and pulmonary diseases, rising incidence of heart strokes, pulmonary embolisms etc. and increasing demand for technologically advanced coagulation testing methods. Increasing prevalence of various cardiovascular and pulmonary diseases can cause life threatening problems, when accompanied by blood clots in the arterial or pulmonary pathway. Thus, the demand for D-dimer tests will augment, and hence will contribute towards the growth of the overall market. Technological advancement in these D-dimer tests will bring more revenues to this market in the coming future. Specific and more sensitive markers are now being used to make these tests more accurate and reliable, which now encompasses automated instrumentation which will further make these tests more standardized.

Request Sample Report @ https://www.persistencemarketresearch.com/samples/20632

Geographically, North America dominates the D-dimer market followed by Europe. Major factors responsible for the dominance of these regions in this market are demand for advanced diagnostics for these life threatening blood clots inside human organ systems. Asia-Pacific region exhibited the fastest rate of growth due to increasing prevalence of cardiovascular diseases in the region combined with increasing affordability and awareness about these diagnostic tests. Some of the key players operating in this market are Abbott Laboratories, Inc., Beckman Coulter Inc.,Bio/Data Corporation,Becton, Dickinson and Company,Corgenix, F. Hoffmann-La Roche Ltd., NANOGEN, Siemens Healthcare, Thermo Fischer Scientific, Inc., and Trinity Biotech plc.

Read Report Overview @ https://www.persistencemarketresearch.com/market-research/d-dimer-market.asp

Firmenportrait:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

Bitte beachten Sie, dass für den Inhalt der hier veröffentlichten Meldung nicht openBroadcast verantwortlich ist, sondern der Verfasser der jeweiligen Meldung selbst. AGB | Haftungsausschluss.